Health Condition 1: N764- Abscess of vulva Health Condition 2: M959- Acquired deformity of musculoskeletal system, unspecified Health Condition 3: I839- Asymptomatic varicose veins of lower extremities Health Condition 4: N476- Balanoposthitis Health Condition 5: N401- Benign prostatic hyperplasia withlower urinary tract symptoms Health Condition 6: N400- Benign prostatic hyperplasia without lower urinary tract symptoms Health Condition 7: K400- Bilateral inguinal hernia, with obstruction, witho
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ASA I and II patients posted for elective surgeries under spinal anaesthesia. Patients who develop shivering.
Exclusion criteria
Exclusion criteria: Refusal to consent for proposed study Infection at injection site History of any bleeding tendency, taking oral anticoagulants (INR more than 1.5) Uncontrolled comorbidities Allergy to the study drug Initial body temperature more than 38 degree celsius or less than 36 degree Celsius. Spine deformity Severe pulmonary or cardiac or hepatic or renal disease Contraindications to spinal anaesthesia Pre-existing neurological deficits
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the comparative efficacy of IV Clonidine versus IV Tramadol in controlling the shivering after spinal anaesthesiaTimepoint: 1,2,5,10,15 minutes post administering drug | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the changes in hemodynamic parameters. To determine the incidence of post-operative shivering. To monitor the occurrence of any adverse effects (bradycardia, nausea, vomiting, dizziness, sedation, pruritus)Timepoint: 1,2,5,10,15,30 minutes post administering drug | — |
Countries
India
Contacts
MS Ramaiah Medical College